Ledger.Open graph →
SEC Form D · filed September 27, 2021

Tarveda Therapeutics, Inc

Offering
$6.0M
Sold
$6.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WATERTOWN, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Guido J. Magni · Watertown, MADirectorMichael J. Metzger · Watertown, MADirectorDennis J. Ausiello · Watertown, MADirectorAymeric J. Sallin · Watertown, MADirectorBrian Roberts · Watertown, MAExec · DirectorNilesh J. Kumar · Watertown, MADirectorSteve Sherrill · Dunwoody, GAExec · DirectorChris C. Wilkins · St. Louis, MODirectorAndy M. Wheeler · St. Louis, MODirectorMichael B. Wainscott · St. Louis, MODirectorMatthew B. Crisp · St. Louis, MODirectorNatalie B. Dinicola · St. Louis, MODirectorKenneth T. Wong · NEW YORK, NYDirectorRichard T. O'Toole · NEW YORK, NYDirectorWilliam B. Janes · Chicago, ILDirectorWilliam B. Janes · Chicago, ILDirectorPeter Wirth · Cambridge, MADirectorMichael E. Price · Austin, TXExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗